| Histone-related genes are hypermethylated in lung cancer and hypermethylated HIST1H4F could serve as a pan-cancer biomarker S Dong*, W Li*, L Wang*, J Hu*, Y Song*, B Zhang, X Ren, S Ji, J Li, P Xu, ... Cancer Research 79 (24), 6101-6112, 2019 | 50 | 2019 |
| SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network W Li*, S Yang*, P Xu*, D Zhang*, Y Tong*, L Chen*, B Jia, A Li, C Lian, ... EBioMedicine 76, 103861, 2022 | 35* | 2022 |
| Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network Y Liang*, Q Lu*, W Li*, D Zhang*, F Zhang*, Q Zou, L Chen, Y Tong, M Liu, ... Nucleic Acids Research 49 (15), 8556-8572, 2021 | 32 | 2021 |
| Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression S Yang*, Y Ling*, F Zhao*, W Li, Z Song, L Wang, Q Li, M Liu, Y Tong, ... Signal Transduction and Targeted Therapy 7 (1), 91, 2022 | 31 | 2022 |
| Guide Positioning Sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor-immune surveillance networks J Li*, Y Li*, W Li*, H Luo*, Y Xi*, S Dong*, M Gao*, P Xu, B Zhang, Y Liang, ... Genome research 29 (2), 270-280, 2019 | 28 | 2019 |
| An epigenetic perspective on tumorigenesis: loss of cell identity, enhancer switching, and NamiRNA network Y Liang*, P Xu*, Q Zou*, H Luo, W Yu Seminars in cancer biology 57, 1-9, 2019 | 21 | 2019 |
| Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening S Dong*, Q Lu*, P Xu*, L Chen*, X Duan, Z Mao, B Zhang, S Long, ... Clinical and Translational Medicine 11 (6), 2021 | 12 | 2021 |
| Hypermethylated PCDHGB7 as a biomarker for early detection of endometrial cancer in endometrial brush samples and cervical scrapings J Yuan*, Z Mao*, Q Lu*, P Xu*, C Wang, X Xu, Z Zhou, T Zhang, W Yu, ... Frontiers in Molecular Biosciences, 1197, 2022 | 9 | 2022 |
| Mutually exclusive epigenetic modification on SIX6 with hypermethylation for precancerous stage and metastasis emergence tracing S Dong*, Z Yang*, P Xu*, W Zheng*, B Zhang*, F Fu, Z Mao, J Yuan, ... Signal Transduction and Targeted Therapy 7 (1), 208, 2022 | 5 | 2022 |
| UHRF1 regulates alternative splicing by interacting with splicing factors and U snRNAs in a H3R2me involved manner P Xu*, L Zhang*, Y Xiao*, W Li*, Z Hu*, R Zhang, J Li, F Wu, Y Xi, Q Zou, ... Human Molecular Genetics 30 (22), 2110-2122, 2021 | 5 | 2021 |
| PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study D Cao*, Z Yang*, S Dong*, Y Li, Z Mao, Q Lu, P Xu, M Shao, L Pan, X Han, ... BMC medicine 22 (1), 55, 2024 | 4 | 2024 |
| An electroosmotic flow-free two-direction migration strategy enables fast affinity capillary electrophoresis to study the weak interactions between basic peptides and RNA Z Yuan, P Xu, F Yu, D Zhang, Q Zhao, W Yu, H Wang Analytical Methods 12 (48), 5833-5838, 2020 | 3 | 2020 |
| Pre-enriched saline gargle samples for detection of SARS-CoV-2 P Xu, J Chen, C Qian, W Yu BioScience Trends 17 (1), 81-84, 2023 | 1 | 2023 |
| How can epigenetic information be inherited to the next generation? P Xu, W Yu Chinese Science Bulletin 61 (32), 3405-3412, 2016 | 1* | 2016 |
| Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma Z Yang*, Q Chen*, S Dong*, P Xu*, W Zheng, Z Mao, C Qian, X Zheng, ... Journal of Translational Medicine 22 (1), 608, 2024 | | 2024 |
| Abstract PO5-06-12: Genetic screen identifies epigenetic drivers of breast cancer brain metastasis J Chen, W Cai, P Xu, D Nguyen, Q Yan Cancer Research 84 (9_Supplement), PO5-06-12-PO5-06-12, 2024 | | 2024 |
| miR‐1246 promotes osteosarcoma cell migration via NamiRNA‐enhancer network dependent on Argonaute 2 S Yang*, Q Zou*, Y Liang*, D Zhang*, L Peng, W Li, W Li, M Liu, Y Tong, ... MedComm 5 (4), e543, 2024 | | 2024 |
